SHARE

During a press release in December 2016, Philip Morris International (PMI) had announced that it submitted a Modified Risk Tobacco Product (MRTP), application with the FDA’s Center for Tobacco Products for its Heat Not Burn device, iQOS.

The public is encouraged to follow the meeting live, by watching a free webcast which can be accessed in the Tobacco Products Scientific Advisory Committee section.
The iQOS device, is a Heat not Burn (HnB) smokeless alternative to combustible cigarettes and works by heating tobacco leaves known as Heets or HeatSticks. These refills which look like short cigarettes, must be inserted into the device and are heated up once iQOS is turned on. They are sold by Philip Morris under the Marlboro brand for approximately the same price as their combustible counterparts.

In two weeks time, on the 24th of January, the FDA’s Tobacco Products Scientific Advisory Committee will be meeting to discuss this MRTP application for the IQOS system with Marlboro Heatsticks, the IQOS system with Marlboro Smooth Menthol Heatsticks, and the IQOS system with Marlboro Fresh Menthol Heatsticks.

How can you be part of this process?

Although seating at the meeting is limited, the public is encouraged to follow live by watching a free webcast which can be accessed in the Tobacco Products Scientific Advisory Committee section. The meeting’s background material should be made available on the website about two business days prior to the event.

Any members of the public wishing to share their opinion, or present any data or information pertaining to iQOS, may do so orally or in writing before January 4, 2018. Further information about doing so may be found on the announcement page

American Vaping Association urges FDA to approve applications for iQOS